NEWS
Free Institutional Consultancy Services
New Feature: Compare Your Institution with the Previous Year
Find a Professional: Explore Experts Across 197 Disciplines in 220 Countries!
Find a Professional
Print Your Certificate
New! Young University / Institution Rankings 2025
New! Art & Humanities Rankings 2025
New! Social Sciences and Humanities Rankings 2025
Highly Cited Researchers 2025
AD
Scientific Index 2025
Scientist Rankings
University Rankings
Subject Rankings
Country Rankings
login
Login
person_add
Register
insights
H-Index Rankings
insights
i10 Productivity Rankings
format_list_numbered
Citation Rankings
subject
University Subject Rankings
school
Young Universities
format_list_numbered
Top 100 Scientists
format_quote
Top 100 Institutions
format_quote
Compare & Choose
local_fire_department
Country Reports
person
Find a Professional
Alexander Davis
University of Sydney - Sydney / Australia
Medical and Health Sciences / Medical Oncology
AD Scientific Index ID: 5148734
Registration, Add Profile,
Premium Membership
Print Your Certificate
Ranking &
Analysis
Job
Experiences (0)
Education
Information (0)
Published Books (0)
Book Chapters (0)
Articles (0)
Presentations (0)
Lessons (0)
Projects (0)
Congresses (0)
Editorship, Referee &
Scientific Board (0 )
Patents /
Designs (0)
Academic Grants
& Awards (0)
Artistic
Activities (0)
Certificate / Course
/ Trainings (0)
Association &
Society Memberships (0)
Contact, Office
& Social Media
person_outline
Alexander Davis's MOST POPULAR ARTICLES
1-)
Relationship between PD-L1 expression and outcome in EGFR-mutant lung cancer patients treated with EGFR tyrosine kinase inhibitorsJ Liu, M Itchins, A Nagrial, WA Cooper, M De Silva, M Barnet, W Varikatt, ...Lung Cancer 155, 28-33, 2021282021
2-)
An update on emerging therapeutic options for malignant pleural mesotheliomaA Davis, H Ke, S Kao, N PavlakisLung Cancer: Targets and Therapy, 1-12, 2022252022
3-)
COVID-19: the use of immunotherapy in metastatic lung cancerAP Davis, M Boyer, JH Lee, SC KaoImmunotherapy 12 (8), 545-548, 2020252020
4-)
Efficacy of immunotherapy in KRAS-mutant non-small-cell lung cancer with comutationsAP Davis, WA Cooper, M Boyer, JH Lee, N Pavlakis, SC KaoImmunotherapy 13 (11), 941-952, 2021172021
5-)
Prolonged disease control on nivolumab for primary pulmonary NUT carcinomaA Davis, A Mahar, K Wong, M Barnet, S KaoClinical Lung Cancer 22 (5), e665-e667, 2021122021
ARTICLES
Add your articles
We use cookies to personalize our website and offer you a better experience. If you accept cookies, we can offer you special services.
Cookie Policy
Accept